phenylpiperazine has been researched along with pyrimidinones in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Gioia, L; Mennini, T; Modica, M; Parotti, L; Russo, F; Salmona, M; Santagati, M; Selvaggini, C | 1 |
| Bloomer, JC; Boyd, HF; Hickey, DM; Ife, RJ; Leach, CA; Macphee, CH; Milliner, KJ; Pinto, IL; Rawlings, DA; Smith, SA; Stansfield, IG; Stanway, SJ; Taylor, MA; Theobald, CJ; Whittaker, CM | 1 |
| Kumar, R; Singh, P | 1 |
3 other study(ies) available for phenylpiperazine and pyrimidinones
| Article | Year |
|---|---|
[[(Arylpiperazinyl)alkyl]thio]thieno[2,3-d]pyrimidinone derivatives as high-affinity, selective 5-HT1A receptor ligands.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Binding, Competitive; Models, Chemical; Piperazines; Pyrimidinones; Rats; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Stereoisomerism; Structure-Activity Relationship | 1997 |
1-(Arylpiperazinylamidoalkyl)-pyrimidones: orally active inhibitors of lipoprotein-associated phospholipase A(2).
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Administration, Oral; Animals; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Metabolic Clearance Rate; Microsomes, Liver; Phospholipases A; Piperazines; Pyrimidinones; Rabbits; Rats | 2001 |
Quantitative structure-activity relationship study of novel alpha1a-selective adrenoceptor antagonists.
Topics: Adrenergic Agonists; Adrenergic alpha-1 Receptor Antagonists; Binding Sites; Humans; Male; Piperazines; Piperidines; Prostatic Hyperplasia; Pyrimidinones; Quantitative Structure-Activity Relationship | 2001 |